Pharmacological characterization of ASP49 PLA2 isolated from Bothrops pauloensis venom / Caracterização farmacologica de uma fosfolipase A2 ASP49 isolada do veneno de Bothrops pauloensis

AUTOR(ES)
DATA DE PUBLICAÇÃO

2008

RESUMO

Bothropic venom has several substances necessary to serpent survival, among them, one of the most widely studied are phospholipase A2 enzymes, that hydrolise sn-2 from membrane phospholipids, releasing lysophospholipids and fatty acids, which beyond playing a biological action in the lipid digestion process, also exhibit a wide variety of pharmacological effects. The present work had as objective to characterize pharmacologically a new phospholipase A2 denominated Bp-13 from the Bothrops pauloensis (endemic serpent to the Brazilian cerrado) venom, evaluating its action at neuromuscular junction, myotoxic effect and edematogenic activity. Bp-13 was purified through chromatographic system, a reverse phase HPLC on a µ-Bondapack C18 column; it has a molecular mass of 14 035 Da, 2,43 nmol/min/mg (30- 35 ºC) catalytic activity Ca2+ dependent, however it was inhibited by Mg2+, Mn2+, Cd2+ and Sr2+. Neuromuscular activity was evaluated in chick biventer cervicis (BC) preparations, extensor digitorum longus (EDL) and mouse phrenic nerve-diaphragm (PND), under indirect electrical stimulation during 120 minutes, at 37oC. Bp-13 (3,56 µM) induced complete and irreversible neuromuscular block in mammalian preparations, which showed to be more sensitive to toxin action than bird preparations. In chick BC preparation, neuromuscular block was 28 ± 2 % after 120 minutes incubation with Bp-13 (7,12 µM) and evoked contracture after exogenous ACh addiction was partially inhibited. Smaller concentrations (0,71 e 1,42 µM) were tested in mouse PND preparation, inducing block of the contractile response in 29 ± 5 % and 55 ± 6 %, respectively. In some experiments, where Ca2+ was substituted for Sr2+ in Tyrode`s solution, there was absence of the Bp-13 characteristic neuromuscular block (3,56 µM); similar event was observed when the bath temperature was altered from 37 ºC to 24 ºC, with a block of 37,4 ± 6 % of the contractile response. Bp-13 (3,56 µM) was able to inhibit contractile response to direct electrical stimulus in previously curarized mouse PND preparations. Through electrophysiological study performed in mouse hemidiaphragm muscle preparation, membrane potentials at rest were evaluated (MP). Bp-13 (3,56 µM) caused a progressive sarcolemma depolarization, reaching values from -80 ± 1 mV (control) until - 37 ± 3 mV after 120 minutes in toxin incubation. In d-tubocurarine (10 µM) pre-treated hemidiaphragm muscle preparations, a depolarization reduction was observed, induced by Bp-13 (-37 ± 3 mV to -58 ± 2 mV). Myotoxicity was evaluated in vitro through morphological analysis of the mouse hemidiaphragm muscle and in vivo through determination of creatinkinase (CK) activity. Regarding morphological analysis, fibers which maintained intact sarcolemma with polygonal shape were considered normal, and fibers which presented hypercontraction of myofibrils, delta type lesion cells, edemaciated and vacuolized, were considered altered fibers. Lesioned fibers from Bothrops pauloensis (100 and 50 µg/mL) venom incubated preparations were 14,4 ± 3 % and 8,7 ± 3 % , respectively; and for Bp-13 fraction (20 e 50 µg/mL) they were 8,3 ± 4 % and 30,6 ± 5 %, respectively. When preparations were Ca2+ was substituted for Sr2+, morphological maintained in Tyrode s solution, where alterations were 36,7 ± 11 %, that is similar to the observed values with Bp-13 in normal Tyrode s solution. The increase in creatinkinase release values after 30 minutes of Bp-13 injection revealed in vivo myotoxic effect, values that returned to normal after 6 hours. Bp-13 concentration of 10 µg injected in rats via intraplantar induced paw edema formation after 15 minutes of toxin injection. In conclusion, Bp-13 is a myotoxin that inhibits temperature and Ca2+ dependent neuromuscular response in mouse EDL and PND isolated preparations, suggesting that its catalytic activity possibly contributes to the pharmacological event, although in vitro myotoxic activity was unaffected by these treatments, indicating a dissociation between these effects

ASSUNTO(S)

junção neuromuscular neuromuscular junction phospholipase fosfolipase a2 bothrops bothrops

ACESSO AO ARTIGO

Documentos Relacionados